欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Lificiguat_170632-47-0_产品详情
170632-47-0
  • names:

    Lificiguat

  • CAS号:

    170632-47-0

    MDL Number:
  • MF(分子式): C19H16N2O2 MW(分子量): 304.34
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Lificiguat
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM003765-10mg 10mg 99.83% ¥ 3982.50 ¥ 3982.50 2-3天
- +
¥ 0.00
YZM003765-5mg 5mg 99.83% ¥ 754.00 ¥ 754.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 170632-47-0
Inchi
InchiKey
分子式 Formula C19H16N2O2
分子量 Molecular Weight 304.34
溶解度Solubility 生物体外In Vitro:DMSO溶解度≥ 100 mg/mL(328.58 mM)H2O< 0.1 mg/mL(insoluble)*"≥" means soluble可溶, but saturation unknown溶解度未知.
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
Lificiguat(CAS:170632-47-0)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 Lificiguat 结合到可溶性鸟苷酸环化酶(sGC)的β亚基,在CO存在条件下,Kd为 0.6-1.1 μM
IntroductionLificiguat binds to the β subunit of soluble guanylyl cyclase(sGC) withKdof 0.6.1 μM in the presence of CO.
Application1
Application2
Application3
Lificiguat 结合到可溶性鸟苷酸环化酶(sGC)的β亚基,在CO存在条件下,Kd为 0.6-1.1 μM。Lificiguat binds to the β subunit ofsoluble guanylyl cyclase(sGC) withKdof 0.6-1.1 μM in the presence of CO.
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Purohit R, et al. YC-1 binding to the β subunit of soluble guanylyl cyclase overcomes allosteric inhibition by the α subunit. Biochemistry. 2014 Jan 14;53(1):101-14.
【2】.Kong J, et al. YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma. Mol Cancer. 2014 Jan 13;13:7.
【3】.Chang LC, et al. YC-1 inhibits proliferation of breast cancer cells by down-regulating EZH2 expression via activation of c-Cbl and ERK. Br J Pharmacol. 2014 Sep;171(17):4010-25.
【4】.Komsuoglu Celikyurt I, et al. Effects of YC-1 on Learning and Memory Functions of Aged Rats. Med Sci Monit Basic Res. 2014 Aug 21;20:130-7.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents